BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)

This study is ongoing, but not recruiting participants.

Study NCT00605215 Information provided by Teva Pharmaceutical Industries

First Received: January 8, 2008 Last Updated: June 10, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Multiple Sclerosis

Additional conditions recognized in this trial

Sclerosis

More general conditions related to this trial

Interventions listed in this trial

laquinimod
placebo
Interferon β-1a (Avonex®)

Additional drug interventions recognized in this trial

Interferon beta 1a
Interferons

More general drug interventions related to this trial

Sponsors listed in this trial